Cleveland Diagnostics nabs Medicare coverage for test that interrogates PSA structural variants
Oct 13, 2022 Cleveland Diagnostics said on Thursday that Medicare administrative contractor CGS Administrators (CGS) has issued a final local coverage decision (LCD) providing favorable coverage for its IsoPSA blood test, which interrogates structural variants of prostate-specific antigen (PSA). Up to 75% of the prostate biopsies performed in the U.S. are negative for high-grade disease, placing […]